Randomized Phase II Open Label Study Of Lenalidomide R-Chop (R2chop) Vs Rchop (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine And Prednisone) I
Posted Date: May 15, 2019
- Investigator: Tahir Latif
- Type of Study: Drug
The purpose of this study is to find out what effects, good and/or bad, the addition of lenalidomide to standard chemotherapy (RCHOP) has on patients and their cancer. Everybody in this study will receive standard chemotherapy. In addition to standard chemotherapy, half of the patients, randomly cho
Criteria:
To Be Eligible For This Study, You Must Have Been Newly Diagnosed With Diffuse Large B Cell Lymphoma
Keywords:
Hematology, Cancer, Diffuse Large B Cell, Lymphoma, E1412
For More Information:
Uc Cancer Center
513-584-7698
ka